Dipeptide inhibitors of angiogenesis

Martin Griffin (Inventor), Mileidys Perez (Inventor)

Research output: Patent

Abstract

The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.
LanguageEnglish
Patent numberGB 1107576.9
IPCA61K38/05
Publication statusPublished - 6 May 2011

Fingerprint

Angiogenesis Inhibitors
Eye Diseases
Dipeptides
Macular Degeneration
Diabetic Retinopathy
transglutaminase 2

Cite this

Griffin, M., & Perez, M. (2011). IPC No. A61K38/05. Dipeptide inhibitors of angiogenesis. (Patent No. GB 1107576.9).
Griffin, Martin (Inventor) ; Perez, Mileidys (Inventor). / Dipeptide inhibitors of angiogenesis. IPC No.: A61K38/05. Patent No.: GB 1107576.9.
@misc{0d491cff3dae42979ea55c89a3a41c9c,
title = "Dipeptide inhibitors of angiogenesis",
abstract = "The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.",
author = "Martin Griffin and Mileidys Perez",
year = "2011",
month = "5",
day = "6",
language = "English",
type = "Patent",
note = "GB 1107576.9; A61K38/05",

}

Griffin, M & Perez, M 2011, Dipeptide inhibitors of angiogenesis, Patent No. GB 1107576.9, IPC No. A61K38/05.

Dipeptide inhibitors of angiogenesis. / Griffin, Martin (Inventor); Perez, Mileidys (Inventor).

IPC No.: A61K38/05. Patent No.: GB 1107576.9.

Research output: Patent

TY - PAT

T1 - Dipeptide inhibitors of angiogenesis

AU - Griffin, Martin

AU - Perez, Mileidys

PY - 2011/5/6

Y1 - 2011/5/6

N2 - The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.

AB - The present invention relates to inhibitors of tissue transglutaminase for use in the inhibition of angiogenesis in a subject. In particular, the invention provides compounds of Formula I for use in the treatment and/or prevention of angiogenic diseases and disorders of the eye, such as diabetic retinopathy and age-related macular degeneration (AMD). The invention further provides methods for inhibiting angiogenesis in a subject.

M3 - Patent

M1 - GB 1107576.9

ER -

Griffin M, Perez M, inventors. Dipeptide inhibitors of angiogenesis. A61K38/05. 2011 May 6.